https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL renews the action plan of the HRS4R strategy

1 de May de 2021

IDIVAL obtained in 2018 the HRS4R seal of excellence in human resources. This seal implies Euraxess recognition of compliance with European standards in human resource management in research and the development of an action plan and objectives proposed by each Institution. IDIVAL is in the implementation phase of the HRS4R strategy and has been working […]

Read more →

The IDIVAL brand exceeds 20000 references in the international scientific literature

The IDIVAL brand, an acronym for the Instituto de Investigación Marqués de Valdecilla, created in 2014, has been cited more than 20,000 times by the international biomedical literature, according to data recently obtained on the Web of Science platform. According to these data, the more than 2,500 works published by the authors who have the […]

Read more →

INTENCIVE project advances in the analysis of e-health practices

10 de March de 2021

INTENCIVE Project, in which IDIVAL participates together with 5 European regions, continues working on its objective of improving the implementation of policies and programmes in terms of health technology innovation-driven and customer-oriented health services in the partner regions. Meetings and visits are regularly held with European partners in order to obtain an overview of the […]

Read more →

Alterations in serum magnesium levels are presented as a new risk factor in liver disease

3 de March de 2021

Individuals with alterations in magnesium levels have an increased risk of presenting fatty liver disease with inflammation and fibrosis, as concluded by a study that has just been published in Journal of Hepatology. Non-alcoholic steatohepatitis, characterized by inflammation and liver fibrosis, is associated with obesity and has a worldwide prevalence of 1.7 billion people. Unhealthy […]

Read more →

Cantabria Cohorte study will monitor 50000 people

1 de March de 2021

Cohorte Cantabria will allow to know in depth the characteristics of the population of Cantabria and its behavior in key aspects for health such as lifestyle habits, risk factors for getting sick, the causes of the main diseases and, even more importantly, favoring development of personalized, predictive and preventive medicine. These are the main objectives […]

Read more →

The PsicAP study proposes adding a psychological treatment in PC

The PsicAP project is the largest mental health care clinical trial ever conducted in Spain to date, about the efficacy of psychological treatment for people with emotional disorders in Primary Care (PC). The study has just published its results in the journal Psychological Medicine. The results confirm that adding a group psychological treatment of 7 […]

Read more →

Resistance test in the Cantabrian Health Service against COVID-19

14 de December de 2020

The crisis generated by the pandemic derived from COVID-19 in extreme contingency scenarios presents a terrible dilemma: first, it is to protect the health of citizens, although that can hibernate the economy and cause a reduction in income with unequal effects by socioeconomic gradient and by Regional Health Service. In this sense, the Transversal Group […]

Read more →

Lung Transplant Patients With COVID-19

10 de December de 2020

Recently, a multicenter retrospective has been published in the American Journal of Transplantation in which six of the seven hospitals that perform lung transplantation in Spain have participated and which are the following: Vall d'Hebron (Barcelona), La Fe (Valencia) , Marqués de Valdecilla (Santander), Reina Sofía (Córdoba), Puerta de Hierro (Madrid), October 12 (Madrid), and […]

Read more →

First results of immunological inflammatory diseases and SARS-CoV-2

8 de September de 2020

The Marqués de Valdecilla University Hospital Rheumatology Unit, in collaboration with the Valdecilla Health Research Institute (IDIVAL), has launched a study to determine the relationship between immunological inflammatory diseases and SARS-CoV-2. Developed by doctors Ricardo Blanco, Miguel Ángel González-Gay and David Martínez-López, the objectives of this research in patients with rheumatological diseases with an immune […]

Read more →

Valdecilla participates in an international study investigating a vaccine against Coronavirus

28 de August de 2020

The Marqués de Valdecilla University Hospital has been one of the 3 Spanish hospitals selected to participate in an international study investigating a vaccine, Ad26COVS, against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease. Thanks to the collaboration of healthy volunteers, the aim is to evaluate the immune response to different doses of […]

Read more →